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Abstract
The septins are a conserved family of proteins that have been proposed to carry out diverse functions. In budding yeast, the
septins become localized to the site of bud emergence in G1 but have not been thought to carry out important functions at
this stage of the cell cycle. We show here that the septins function in redundant mechanisms that are required for formation
of the bud neck and for the normal pattern of cell growth early in the cell cycle. The Shs1 septin shows strong genetic
interactions with G1 cyclins and is directly phosphorylated by G1 cyclin-dependent kinases, consistent with a role in early
cell cycle events. However, Shs1 phosphorylation site mutants do not show genetic interactions with the G1 cyclins or
obvious defects early in the cell cycle. Rather, they cause an increased cell size and aberrant cell morphology that are
dependent upon inhibitory phosphorylation of Cdk1 at the G2/M transition. Shs1 phosphorylation mutants also show
defects in interaction with the Gin4 kinase, which associates with the septins during G2/M and plays a role in regulating
inhibitory phosphorylation of Cdk1. Phosphorylation of Shs1 by G1 cyclin-dependent kinases plays a role in events that
influence Cdk1 inhibitory phosphorylation.
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Introduction
G1 cyclins bind and activate cyclin-dependent kinases (CDKs)
to initiate cell cycle events in G1 [1,2]. In budding yeast, an
important function of the G1 cyclins is to initiate growth of a new
daughter cell [3–6]. There are two CDKs that function during G1
in budding yeast, called Cdk1 and Pho85, which are activated by
numerous different cyclins [1]. Cdk1 is activated by Cln1, Cln2,
and Cln3, while Pho85 is activated by Pcl1 and Pcl2, as well as a
number of additional cyclins that do not appear to directly
regulate G1 events. The G1 cyclins are highly redundant. For
example, loss of Cln3 or Cln1 and Cln2 causes delayed initiation
of bud growth, but loss of all three cyclins leads to a failure to
initiate bud growth [4,5]. Similarly, loss of Pcl1 and Pcl2 causes no
obvious phenotype, but cells lacking Pcl1, Pcl2, Cln1, and Cln2
fail to form a focused bud neck and show severe defects in the
pattern of bud growth [3,7,8]. The extensive redundancy of G1
cyclins implies the existence of multiple overlapping pathways that
control G1 events.
The mechanisms used by the G1 cyclins to control G1 events
are poorly understood. CLN1 and CLN2 interact genetically with a
member of the septin family of proteins, which suggests that
septins may function in events controlled by G1 cyclins [9]. There
are five septins expressed in vegetatively growing yeast cells that
are referred to as Cdc3, Cdc10, Cdc11, Cdc12, and Shs1 [10–12].
The septins form a tight complex with each other and are localized
to the bud neck [13–16]. Loss of Cdc3, Cdc10, Cdc11, or Cdc12
causes cells to arrest or delay at G2/M while polar bud growth
continues, which results in aberrant growth of highly elongated
cells [11]. In contrast, loss of Shs1 causes only a mild and weakly
penetrant elongated bud phenotype, and the role of this septin has
therefore been unclear [17,18]. The septins have been proposed to
function as cytoskeletal elements, scaffolds, factors involved in
vesicle targeting or fusion, or as a diffusion barrier that prevents
movement of membrane proteins between the mother and
daughter cell [10,12,19–30]. Septins have domains that bind to
GTP and phosphoinositides, but the functions of these domains
are poorly understood [10].
Although loss of septin function causes a G2/M arrest in
budding yeast, there is some evidence that the septins may also
carry out functions early in the cell cycle. A unique allele of Cdc12
is synthetically lethal with cln1D cln2D, and the septins become
localized to the site of bud emergence in G1 [9,16]. In addition,
loss of septin function causes the newly emerging bud to be slightly
elongated and to have a misshapen bud neck [31,32]. Important
functions for the septins during G1 may be masked by the
existence of redundant pathways that control G1 events.
In this study, we tested whether septins function in pathways
controlled by G1 cyclins and identified a septin-dependent
pathway that controls the pattern of cell growth early in the cell
cycle. Moreover, we found that the Shs1 septin shows strong
genetic interactions with G1 cyclins and is a direct target of CDKs
associated with G1 cyclins. However, phosphorylation of Shs1
does not appear to play a role in septin-dependent pathways that
control the pattern of cell growth during G1. Rather, Shs1
phosphorylation appears to influence events that regulate
PLoS ONE | www.plosone.org 1 April 2008 | Volume 3 | Issue 4 | e2022inhibitory phosphorylation of Cdk1 at the G2/M transition.
Phosphorylation of Shs1 by G1 cyclin-dependent kinases could
therefore play a role in mechanisms that help link entry into
mitosis to successful completion of G1 events.
Results
Genetic interactions suggest that the Shs1 septin may
function in G1 pathways
Since an allele of CDC12 was previously found to show synthetic
lethal interactions with cln1D cln2D, we tested whether this is also
true for shs1D [9]. We were unable to recover viable cln1D cln2D
shs1D haploids, which suggested that shs1D is synthetically lethal
with cln1D cln2D. To further confirm that shs1D is synthetically
lethal with cln1D cln2D, we generated a shs1D cln1D GAL1-CLN2
strain, in which the expression of CLN2 could be repressed by
dextrose. This strain grew normally on galactose, but failed to
grow on dextrose (Figure 1A). Loss of SHS1 was not synthetically
lethal with pcl1D pcl2D. To test for additional genetic interactions
between the septins and cln1D cln2D, we determined whether a
commonly used temperature sensitive allele of CDC12, cdc12-6,
showed a genetic interaction with cln1D cln2D. In this case, we
found that cln1D cln2D lowered the restrictive temperature of the
cdc12-6 allele (Figure 1B). Thus, several septins and septin alleles
show strong genetic interactions with G1 cyclins. The finding that
SHS1 is essential for viability in cln1D cln2D cells but not in wild
type cells suggests that it may function in redundant pathways that
control G1 events.
Septins are required for the normal pattern of cell growth
in cln1D cln2D cells
We used the cdc12-6 cln1D cln2D cells and the shs1D cln1D GAL1-
CLN2 cells to determine the consequences of a loss of septin
function in cells that lack Cln1 and Cln2. We first used centrifugal
elutriation to synchronize cdc12-6, cln1D cln2D, and cdc12-6 cln1D
cln2D cells in early G1 and then released them at the restrictive
temperature for the cdc12-6 allele (34uC). The cdc12-6 cln1D cln2D
cells were unable to form buds with normal morphology and
largely failed to direct growth to the daughter bud (Figure 2A).
The cells were also unable to form a normal bud neck with a well-
defined constriction between the mother and daughter cell.
We next shifted rapidly growing shs1D cln1D GAL1-CLN2 cells
from galactose to dextrose. After 4.5 hours, some cells arrested as
large unbudded cells, while others arrested with small poorly
formed buds that lacked a well-defined bud neck (Figure 2B). We
were unable to synchronize the shs1D cln1D GAL1-CLN2 cells by
centrifugal elutriation because cells carrying shs1D form clumps.
These results demonstrate that loss of Shs1 or Cdc12 in cells that
lack Cln1 and Cln2 causes defects in the pattern of cell growth that
are distinct from the defects caused in wild type cells.
Figure 1. shs1D and cdc12-6 are synthetically lethal with cln1D
cln2D. (A) Growth of cln1D GAL1-CLN2, shs1D, and shs1D cln1D GAL1-
CLN2 cells was monitored on YP media containing galactose or dextrose
at 30uC. (B) Growth of cln1D cln2D, cdc12-6, and cdc12-6 cln1D cln2D
cells was monitored on YPD plates at 25uC and 28uC.
doi:10.1371/journal.pone.0002022.g001
Figure 2. Loss of Cdc12 or Shs1 in cln1D cln2D cells causes
defects in formation of the bud neck and the pattern of
growth. (A) cdc12-6, cln1D cln2D, and cdc12-6 cln1D cln2D cells were
synchronized by centrifugal elutriation and released into YPD media at
34uC, the restrictive temperature for the cdc12-6 allele. Micrographs
were taken at the indicated timepoints after release. Bar, 5 mm for all
panels (B) Cells of the indicated genotypes were grown to log phase in
YP media containing galactose and transferred to YPD media at 30uC.
Micrographs were taken 4.5 hours after release into YPD media. Bar,
5 mm for both panels.
doi:10.1371/journal.pone.0002022.g002
The Septins Function in G1
PLoS ONE | www.plosone.org 2 April 2008 | Volume 3 | Issue 4 | e2022The Shs1 septin is required for septin localization in cells
that lack Cln1 and Cln2
Loss of Cdc3, Cdc10, Cdc11 or Cdc12 results in rapid loss of
localization of the septins; however, loss of Shs1 has no effect on
septin localization [16,33,34]. Since Shs1 is essential for viability in
cln1D cln2D cells, we tested whether Shs1 is essential for
localization of the other septins in cells that lack Cln1 and Cln2.
We shifted shs1D cln1D GAL1-CLN2 and cln1D GAL1-CLN2 control
cells into dextrose for 4.5 hours and used immunofluorescence to
test for Cdc11 localization. Most shs1D cln1D GAL1-CLN2 cells
showed a complete failure to localize Cdc11 (Figure 3A), although
some unbudded cells had diffuse Cdc11 localization over one end
of the cell (arrow, Figure 3B). Of the few budded shs1D cln1D
GAL1-CLN2 cells, only 30% had polarized Cdc11 localization in
the mother or daughter cell and the Cdc11 localization in the
majority of these cells was aberrant (arrow, Figure 3C). Only 7.5%
of budded cells had normal Cdc11 localization (Figure 3F). In
cln1D GAL-CLN2 control cells, 100% of budded cells had polarized
Cdc11 localization and 80% had normal Cdc11 localization
(arrowhead, Figure 3D and 3F). In addition, the defects in Cdc11
localization that were observed in cells that lack Cln1 and Cln2
were less severe than the defects observed in cells that lack Shs1,
Cln1, and Cln2 (arrow, Figure 3E). These results demonstrate that
Shs1 is required for the normal localization of Cdc11 in cells that
lack Cln1 and Cln2.
Shs1 is a target of multiple CDK-cyclin complexes during
G1
The finding that Shs1 is essential for viability and for septin
localization in cells that lack Cln1 and Cln2 suggested that it may
function in pathways regulated by G1 cyclins. To test this idea, we
first assayed the phosphorylation state of Shs1 during the cell cycle
in wild type and pcl1D pcl2D cells. Previous work demonstrated
that Shs1 undergoes phosphorylation that can be detected by a
shift in electrophoretic mobility [13]. Wild type and pcl1D pcl2D
cells were released from a G1 arrest and phosphorylation of Shs1
was monitored during the cell cycle by Western blotting
(Figure 4A). Levels of the G1 cyclin Cln2 and the mitotic cyclin
Clb2 were also monitored to provide markers for cell cycle
progression. In wild type cells, multiple phosphorylated forms of
Shs1 could be detected during the cell cycle. We refer to the most
slowly migrating forms of Shs1 as the upper forms, and the most
rapidly migrating form of Shs1 as the lower form (Figure 4B). At
30 minutes, the upper form of Shs1 underwent further hyperpho-
sphorylation that could be detected as a shift in electrophoretic
mobility and a broadening of the electrophoretic band. The
hyperphosphorylation occurred concurrently with synthesis of the
G1 cyclin Cln2 and prior to synthesis of Clb2, which indicated that
it was initiated during G1/S phase. Similar hyperphosphorylated
forms of Shs1 failed to appear when Cln2 was synthesized in pcl1D
pcl2D cells (Figure 4A).
We next tested whether other G1 cyclin/CDK complexes also
play a role in phosphorylation of Shs1. To do this, we first assayed
Shs1 phosphorylation in log phase populations of pcl1D pcl2D,
pho85D, cln1D cln2D, and cln3D cells (Figure 4C). Consistent with
the results from synchronized cells, the upper form of Shs1 failed
to become fully hyperphosphorylated in rapidly growing pcl1D
pcl2D cells. Similarly, the upper form of Shs1 failed to become fully
hyperphosphorylated in pho85D cells. In cln1D cln2D cells, there
was little effect on the hyperphosphorylated upper forms of Shs1,
but we consistently observed an increase in the hypopho-
sphorylated lower form of Shs1. In cln3D cells, the hyperpho-
sphorylated upper forms of Shs1 were significantly reduced. We
also assayed Shs1 phosphorylation in cln1D cln2D GAL1-CLN3 cells
after repression of CLN3 expression with dextrose. The hyperpho-
sphorylated upper forms of Shs1 were rapidly and significantly
reduced when the cln1D cln2D GAL1-CLN3 cells were transferred
to dextrose (Figure 4D). Previous work has shown that Cln3 plays
an important role in pathways that help trigger transcription of
Pcl1, Pcl2, Cln1, and Cln2, which may explain the strong effects of
loss of Cln3 on Shs1 phosphorylation [3,35,36].
To test whether Shs1 hyperphosphorylation is primarily
dependent upon G1 cyclins, we also assayed the effects of
depletion of mitotic cyclins on Shs1 phosphorylation. As with
G1 cyclins, there are multiple redundant mitotic cyclins, which are
called Clb1, Clb2, Clb3, and Clb4 [37]. Clb2 is the most
important mitotic cyclin and cells can be made dependent upon
Clb2 for viability by deleting the genes for the other mitotic
cyclins. We assayed Shs1 phosphorylation in clb1D clb3D clb4D
GAL1-CLB2 cells after a shift to dextrose to repress Clb2
transcription (Figure 4E). The upper phosphorylated forms of
Shs1 were not significantly reduced when cells were depleted of all
mitotic cyclins. Depletion of mitotic cyclins caused Shs1 to
accumulate in hyperphosphorylated forms because mitotic cyclins
Figure 3. Shs1 is required for normal localization of the Cdc11
septin in cln1D cln2D cells. (A–C) shs1D cln1D GAL1-CLN2 cells and
(D–E) cln1D GAL1-CLN2 control cells were grown to log phase in YP
media containing galactose and switched to YPD media for 4.5 hours.
Cdc11 localization was determined with an anti-Cdc11 antibody. Arrows
point to abnormal Cdc11 localization. The arrow head points to normal
Cdc11 localization. Bar, 5 mm for all panels. (F) The percentage of
budded cells in cln1D GAL1-CLN2 and shs1D cln1D GAL1-CLN2 cells that
had any polarized Cdc11 localization in the mother or daughter cell was
determined, including cells that had polarized but abnormal localization
of Cdc11. The percentage of budded cells that had normal Cdc11
localization at the bud neck was also determined. 200 cells were
counted for each strain.
doi:10.1371/journal.pone.0002022.g003
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with high levels of G1 CDK activity (Figure 4E) [38]. Together,
these results demonstrate that Cdk1 and Pho85 associated with G1
cyclins are required for full hyperphosphorylation of Shs1 in vivo.
Pho85-Pcl1 and Cdk1-Cln2 can directly
hyperphosphorylate Shs1
We next addressed whether G1 CDKs can directly hyperpho-
sphorylate Shs1. We initially focused on phosphorylation of Shs1
by Pho85 because active Pho85-Pcl1 complexes can be readily
purified after expression in bacteria [39]. In addition, Shs1 was
previously identified in a high-throughput screen for proteins that
are phosphorylated by Pho85-Pcl1 or Pho85-Pho80 [39]. In this
screen, Shs1 was found to be a highly specific substrate of Pho85-
Pcl1 when compared with Pho85-Pho80; however, the experi-
ments did not determine whether Pho85-Pcl1 is capable of
generating the fully hyperphosphorylated upper forms of Shs1 that
are observed in vivo. To carry out a more detailed analysis of Shs1
phosphorylation, we used immunoaffinity chromatography to
purify Shs1-3XHA from yeast cells to use as a substrate for kinase
reactions. The immunoaffinity purification was carried out in the
presence of 1M KCl to remove all but the most tightly associated
proteins. Under these conditions, Shs1-3XHA was found in a
complex with the other septins, as previously reported (Figure 5A,
first lane) [13]. We also treated Shs1-3XHA with lambda
phosphatase during the purification to generate the fully
dephosphorylated form of Shs1 (Figure 5A, second lane).
6XHIS-Pho85 and GST-Pcl1 were co-expressed in bacteria and
purified by affinity chromatography (Figure 5B). Incubation of
purified Shs1-3XHA with purified 6XHIS-Pho85/GST-Pcl1
caused Shs1-3XHA to shift to two discrete hyperphosphorylated
forms (Figure 5C). The fully hyperphosphorylated form of Shs1
generated in vitro was similar to the hyperphosphorylated upper
form of Shs1 observed in vivo. Since Cln cyclins are also required
in vivo for full Shs1 phosphorylation, we tested whether Cdk1-
Cln2 can hyperphosphorylate Shs1. We used immunoaffinity
chromatography to purify Cdk1/3XHA-Cln2 from yeast. Incu-
bation of Cdk1/3XHA-Cln2 with the purified septin complexes
caused Shs1 to undergo a shift in electrophoretic mobility similar
to the shift induced by Pho85-Pcl1. These results show that Pho85-
Pcl1 and Cdk1-Cln2 are capable of generating at least some of the
hyperphosphorylated forms of Shs1 observed in vivo.
Figure 4. Shs1 phosphorylation is dependent upon multiple CDK-cyclin complexes. (A) Wild type and pcl1D pcl2D cells were arrested in
G1 by the addition of a factor. The cells were released from the arrest and time points were taken every 10 minutes. The behavior of Shs1, Cln2-3XHA,
and Clb2 was followed by Western blotting. The Cln2-3XHA and Clb2 time courses are from a different experiment, but the timing of Shs1
phosphorylation during the cell cycle was similar in both experiments. (B) The sample taken from wild type cells at 60 minutes in the time course
shown in Figure 4A was labeled to indicate the different isoforms of Shs1. (C) Western blot analysis of Shs1 phosphorylation in log phase populations
of wild type, pcl1D pcl2D, pho85D, cln1D cln2D, and cln3D cells. A loading control is not shown because slightly different amounts of protein were
loaded to obtain exposures that allow accurate comparison of the relative amounts of phosphorylation isoforms. (D) cln1D cln2D GAL1-CLN3 and (E)
clb1D clb3D clb4D GAL1-CLB2 cells were grown to log phase in YP media containing galactose and released into YPD media for the indicated times.
The behavior of Shs1 was followed by Western blotting. The same samples were probed with an anti-Nap1 antibody to provide loading controls.
doi:10.1371/journal.pone.0002022.g004
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To further confirm that Pho85-Pcl1 phosphorylates Shs1 in
vivo, we used mass spectrometry to map phosphorylation sites on
both of the phosphorylated forms of Shs1 generated in vitro. We
also mapped in vivo phosphorylation sites and then compared
these to the in vitro sites. To map in vivo phosphorylation sites, we
purified Shs1-3XHA from yeast cells by immunoaffinity chroma-
tography in the presence of high salt and high concentrations of
phosphatase inhibitors. Excellent sequence coverage was obtained
for all of the mapping experiments (greater than 85%). The results
are summarized in Table 1 and Figure 6A. Five phosphorylation
sites were identified on the partially hyperphosphorylated form of
Shs1 generated in vitro, and twelve were identified on the fully
hyperphosphorylated form. Of the five minimal CDK consensus
sites in Shs1 (SP or TP), three were found to be phosphorylated in
the partially hyperphosphorylated form of Shs1 and four were
found in the fully hyperphosphorylated form. In each case where a
CDK consensus site was not detected on Shs1 phosphorylated in
vitro, the peptides containing that site were not covered by the
mapping so it is possible that the site was phosphorylated. The
fully hyperphosphorylated form of Shs1 generated in vitro was
phosphorylated on eight non-consensus sites in addition to the
consensus sites.
The Shs1-3XHA isolated from yeast cells to map in vivo
phosphorylation sites was phosphorylated on a total of nineteen
sites, including all five CDK consensus sites. Four of the eight non-
consensus sites that were phosphorylated by Pho85-Pcl1 in vitro
were also phosphorylated in vivo. The in vivo mapping
experiments may have missed some sites because they were
carried out with total Shs1-3XHA isolated from asynchronous
cells, rather than with specific isoforms, to ensure that there was no
bias towards specific phosphorylation sites. As a result, the Shs1-
3XHA used for in vivo mapping was not quantitatively
phosphorylated, whereas the Shs1 phosphorylated in vitro was
quantitatively phosphorylated, which may have led to better
detection of some phosphorylation sites on the in vitro phosphor-
ylated form of Shs1.
To assess the significance of Pho85-Pcl1 dependent phosphor-
ylation of Shs1, we generated four phosphorylation site mutants of
Shs1 (Figure 6A). In one version, we converted the two Pho85
consensus sites (S/TPXI/L) to alanines (referred to as shs1-ps1)
[40]. In another version, we converted all five minimal CDK
consensus sites to alanines (shs1-ps2). We also made two mutant
versions of Shs1 in which we mutated non-consensus sites in
addition to the five consensus sites. In shs1-ps3, we mutated only
the non-consensus sites that were phosphorylated in vitro and in
vivo. In shs1-ps4, we mutated all non-consensus sites that were
phosphorylated in vitro. In the mapping experiments we
sometimes identified phosphorylation sites that occurred at two
or more adjacent serines or threonines, and it was impossible to
unambiguously identify which serine or threonine was phosphor-
ylated. In these cases, it seemed likely that the adjacent serines or
threonines could be phosphorylated in vivo. We therefore mutated
each of the adjacent serines or threonines at the site to ensure that
all phosphorylation would be eliminated. All four shs1-ps mutants
were integrated at the endogenous SHS1 locus.
To test the effects of these phosphorylation site mutants on Shs1
phosphorylation, we assayed Shs1 phosphorylation in log phase
populations of wild type, shs1-ps1, shs1-ps2, shs1-ps3, and shs1-ps4
cells (Figure 6B). All mutants showed a loss of phosphorylation,
each one varying depending on the number and type of mutation.
The mutant versions of Shs1 in which only the CDK consensus
sites were mutated to alanines (shs1-ps1 and shs1-ps2) showed a
decrease in the most hyperphosphorylated upper form of Shs1,
whereas the mutant versions that also included the non-consensus
Figure 5. Pho85-Pcl1 can hyperphosphorylate Shs1 in vitro. (A) A Coomassie blue-stained polyacrylamide gel that shows purified Shs1-3XHA
with or without treatment with lambda phosphatase. The asterisk marks a background band that is present in some septin purifications. (B) A
Coomassie blue-stained polyacrylamide gel that shows purified 6HIS-Pho85/GST-Pcl1 co-purified from bacteria. A number of background bands co-
purify with 6HIS-Pho85/GST-Pcl1. The band migrating around 65 KD is most likely a heat shock protein. (C) Purified dephosphorylated Shs1-3XHA
complexes were incubated with increasing amounts of purified 6XHIS-Pho85/GST-Pcl1 in the presence of ATP for 1 hour at 30uC (right panel). The
reactions were then loaded onto a 10% SDS-polyacrylamide gel and the phosphorylation state of Shs1 was monitored by Western blotting. As a
control, purified Shs1-3XHA and purified 6XHIS-Pho85/GST-Pcl1 were incubated individually with ATP (left panel). (D) Purified dephosphorylated
Shs1-3XHA complexes were incubated with purified 3XHA-Cln2/Cdk1 complexes for 30 minutes at 30uC. The reactions were then loaded onto a 10%
SDS-polyacrylamide gel and the phosphorylation state of Shs1 was monitored by Western blotting.
doi:10.1371/journal.pone.0002022.g005
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Peptide Sequence Site(s) In vitro (partial) In vitro (full) In vivo
Ac-STAST*PPINLFR T6 +
TAST*PPINLFR T6 ++
SNASI(SS)*NPEVK S63 (S64) +
ADS*FTKEELTQFR S221 +
KFEVDPEDDDLES*MEENQAL S259 +
LSSVANAEEIGPN(ST)*KR S350 (T351) +
RSEKLSSVANAEEIGPN(ST)*KRQSNAPSLSNF S350 (T351) +
SSVANAEEIGPN(ST)*KRQSNAPSLSNF S350 (T351) ++
SSVANAEEIGPNSTKRQS*NAPSLSNF S355 +
STKRQS*NAPS*LSNF S355, S359 +
RQSNAPS*LSNF S359 +
SSVANAEEIGPNSTKRQSNAPS*LSNF S359 +
STKRQSNAPS*LSNF S359 +
KRQSNAPS*LSNF S359 +
ASLIST*GQFNSSQTL S369 +
ASLISTGQFN(SS)*QTL S374 (S375) +
ISTGQFN(SS)*QTL S374 (S375) +
ANNLRADT*PRNQ T386 +
ANNLRADT*PRNQVSGNF T386 ++ +
RADT*PRNQVSGNF T386 ++ +
ADT*PRNQVSGNFK T386 +
KENEYEDNGEHDS*AENEQEMSPVRQL S408 +
ENEYEDNGEHDS*AENEQEMSPVR S408 +
NQVSGNFKENEYEDNGEHDS*AENEQEMSPVR S408 +
KENEYEDNGEHDSAENEQEMS*PVRQL S416 ++
ENEYEDNGEHDSAENEQEMS*PVR S416 ++
NQVSGNFKENEYEDNGEHDSAENEQEMS*PVR S416 ++
KTESS*PKFL S441 +
FLNS*PDLPER S447 ++ +
FLNS*PDLPERT*K S447, T454 +
NIS*ETVPYVLR S460 ++
NISET*VPYVLR T462 +
INQNKLNG(SSSS)*IN S519 (S520, S521, S522) ++
INQNKLNG(SSSS)*INSL S519 (S520, S521, S522) +
INQNKLNG(SSSS)*INSLQQSTR S519 (S520, S521, S522) +
LNG(SSSS)*INSLQQSTR S519 (S520, S521, S522) ++
INQNKLNGS*(SSS)*INSLQQSTR S519, S522 (S520, S521) +
LNGS*(SSS)*INSLQQSTR S519, S522 (S520, S521) +
LNGSSSSINS*LQQSTR S525 +
LNGSS(SS)*INS*LQQSTR S522 (S521), S525 +
LINQNKLNGS*(SSS)*INS*LQQSTR S519, S520 (S521, S522), S525 +
INQNKLNG(SSSS)**INS*LQQSTR 2 (S519, S520, S521, S522), S525 +
INQNKLNGSSS*SINS*LQQSTR S521, S525 +
LNGSSSSINSLQQ(ST)*R S529 (T530) +
KNDT*YTDLASIASGR T539 +
NDT*YTDLASIASGR T539 +
SQIKKNDT*YTDL T539 +
SQIKKND(TYT)*DLASIA T539 (Y540, T541) +
KND(TYT)*DLASIASGR T539 (Y540, T541) +
KNDTYTDLAS*IASGR S545 ++
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Peptide Sequence Site(s) In vitro (partial) In vitro (full) In vivo
NDTYTDLAS*IASGR S545 +
KNDT*YTDLAS*IASGR T539, S545 +
NDT*YTDLAS*IASGR T539, S545 +
KNDTYTDLASIAS*GR S548 +
NDTYTDLASIAS*GR S548 +
NDT*YTDLASIAS*GR T539, S548 +
KNDTYTDLAS*IAS*GR S545, S548 +
NDTYTDLAS*IAS*GR S545, S548 +
KNDT*YTDLAS*IAS*GR T539, S545, S548 +
NDT*YTDLAS*IAS*GR T539, S545, S548 +
Two independent digestions (trypsin and chymotrypsin) were performed on Shs1 gel bands, which resulted in high sequence coverage and redundant and therefore
more reliable phosphorylation site identifications. Phosphorylation sites are denoted in the peptide sequence by an asterisk. When MS/MS spectra did not contain
enough fragment ions to unambiguously assign the phosphorylation site within the peptide sequence, all possibly modified amino acids are grouped in parenthesis in
column 1 and also the most likely position is indicated in column 2, followed by alternate positions in parenthesis. The column labeled ‘‘In vitro (partial)’’ refers to the
partially phosphorylated form of Shs1 generated in vitro. The column labeled ‘‘In vitro (full)’’ refers to the fully phosphorylated form of Shs1 generated in vitro.
doi:10.1371/journal.pone.0002022.t001
Figure 6. Mapping and analysis of Pho85-Pcl1 phosphorylation sites on Shs1. (A) The distribution of in vitro and in vivo phosphorylation
sites on Shs1, and a summary of the phosphorylation sites mutated in shs1-ps mutants. Minimal CDK-consensus sites (SP or TP) are denoted in red. (B)
Shs1 phosphorylation was analyzed in log phase populations of wild type, shs1-ps1, shs1-ps2, shs1-ps3, and shs1-ps4 cells by Western blotting. A
loading control is not shown because slightly different amounts of protein were loaded to obtain exposures that allow accurate comparison of the
relative amounts of phosphorylation isoforms. (C) Wild type, shs1-ps1, and shs1-ps2 cells were released from an a factor arrest and samples were taken
every 10 minutes. Shs1 phosphorylation and Clb2 levels were monitored by Western blotting.
doi:10.1371/journal.pone.0002022.g006
The Septins Function in G1
PLoS ONE | www.plosone.org 7 April 2008 | Volume 3 | Issue 4 | e2022site mutations (shs1-ps3 and shs1-ps4) showed a more dramatic loss
of phosphorylation. These results demonstrate that both CDK
consensus and non-consensus sites are phosphorylated in vivo.
Note that the shs1-ps4 mutant was less phosphorylated than the
shs1-ps3 mutant. This suggests that the four non-consensus sites
that were mapped in vitro, but not in vivo, are genuine
phosphorylation sites in vivo. We also tested whether the upper
form of Shs1 that remained in shs1-ps1 and shs1-ps2 became
hyperphosphorylated during the cell cycle (Figure 6C). The levels
of the upper form changed in both shs1-ps1 and shs1-ps2 during the
cell cycle, but in the shs1-ps1 mutant, which retains three
functional consensus sites, the upper form became hyperpho-
sphorylated at 40 minutes, similar to wild type.
Mutation of the sites that were phosphorylated by Pho85-Pcl1
in vitro caused a much greater loss of in vivo phosphorylation than
pho85D. Moreover, the loss of phosphorylation observed for the
shs1-ps3 mutant closely resembled the loss of phosphorylation
observed in cln1D cln2D GAL1-CLN3 cells after repression of CLN3
transcription. Since Cln3 plays a role in pathways that initiate
transcription of Pcl1, Pcl2, Cln1, and Cln2, these observations
suggest that Cdk1 and Pho85 associated with G1 cyclins act
redundantly to phosphorylate Shs1 in vivo [3,35,36].
Known functions of Shs1 are dependent upon
phosphorylation
We next characterized the functional significance of Shs1
phosphorylation. Surprisingly, we found that the shs1-ps mutants
caused little or no phenotype in cln1D GAL-CLN2 cells when grown
in dextrose. In addition, the shs1-ps mutants localized to the bud
neck (Figure S1). These observations demonstrate that CDK-
dependent phosphorylation of Shs1 is not required for the roles
that Shs1 plays in regulating the pattern of cell growth or septin
localization early in the cell cycle. These observations also show
that the shs1-ps mutants retain key functions, which suggests that
the mutations did not cause non-specific loss of function.
We next tested whether the shs1-ps mutants have effects on the
interaction of Shs1 with the Gin4 kinase, since previous work
found that Shs1 and the other septins associate with Gin4 in an
Shs1-dependent manner when cells enter mitosis [13]. We
immunoprecipitated Gin4 from wild type, shs1-ps2, shs1-ps3, and
shs1-ps4 cells that were arrested in mitosis and probed for the
presence of associated Shs1 (Figure 7A). The shs1-ps2 protein was
found predominantly in a hypophosphorylated lower form in cells
arrested in mitosis, and this form failed to associate with Gin4. In
contrast, a hyperphosphorylated upper form of shs1-ps2 bound
efficiently to Gin4. The shs1-ps3 protein associated with Gin4 with
high efficiency, while shs1-ps4 showed a reduced association with
Gin4 when compared to shs1-ps3. These results suggest that Shs1
phosphorylation plays a role in regulating the association of Shs1
with Gin4. However, the mechanisms by which Shs1 phosphor-
ylation controls association with Gin4 appear to be complex. One
model that could explain these observations is that phosphoryla-
tion of a subset of sites promotes association of Gin4 with Shs1,
while phosphorylation of other sites inhibits the association.
Loss of the Gin4 kinase causes a prolonged G2/M delay
[13,17,41,42]. Polar growth continues during the delay, which leads
to growth of cells that are larger and more elongated than wild type
cells. The delay is caused by a failure to inactivate the Swe1 kinase,
which blocks entry into mitosis by phosphorylating and inhibiting
Cdk1 [41]. Thus, the G2/M delay and cell size defects caused by
gin4D are rescued by swe1D. Conversely, the phenotype of gin4D is
strongly enhanced in clb1D clb3D clb4D cells, which have reduced
mitotic Cdk1 activity because they lack redundant mitotic cyclins
[42]. Previous work found that shs1D causes an increased cell size
and cell elongation phenotype that is similar to the phenotype
caused by gin4D [17,18]. Moreover, the phenotype of shs1D is
enhanced in clb1D clb3D clb4D cells [17]. We therefore tested
whether the shs1-ps mutants cause a phenotype that is similar to
shs1D. We found that the shs1-ps mutants were significantly larger
than wild type cells and slightly elongated at 34uC, although the
elongated cell phenotype was not as penetrant as the phenotype
caused by shs1D (Figure 7B). In addition, the phenotype of shs1-ps4
was enhanced in cells that are dependent upon the Clb2 mitotic
cyclin for survival, as observed for shs1D (Figure 7C). The
phenotype of shs1-ps4 clb1D clb3D clb4D cells was rescued by swe1D,
which indicates that shs1-ps4 causes a Swe1-dependent G2/M
delay. Thus, failure to phosphorylate Shs1 causes a failure to
inactivate Swe1 in a timely manner at the G2/M transition.
Discussion
The septins function in redundant pathways that control
the pattern of cell growth early in the cell cycle
A number of observations suggest that the septins function in
pathways initiated by G1 cyclins to control the pattern of cell
growth. The septins show strong synthetic lethal interactions with
redundant G1 cyclins, and loss of Shs1 or Cdc12 in cln1D cln2D
cells causes defects in formation of a focused bud neck and a
failure to restrict growth to the daughter cell. Since the bud neck is
formed in late G1, it seems likely that the septins execute functions
when they first localize to the site of bud emergence in G1. The
finding that Shs1 is required for normal localization of Cdc11 in
unbudded cells that lack Cln1 and Cln2 further supports the idea
that the septins carry out functions in G1. Finally, previous work
found that G1 CDK activity plays a role in localizing the septins to
a ring early in the cell cycle, which demonstrates that the septins
are targets of pathways initiated by G1 cyclins [43,44]. These
observations might be explained by the existence of redundant
septin-dependent and septin-independent pathways that control
formation of the bud neck and the pattern of bud growth. The
genetic interactions between the septins and cln1D cln2D suggest
that the septin-independent pathway is initiated primarily by Cln1
and Cln2, while the septin-dependent pathway is initiated by Pcl1
and Pcl2. Recent studies found that the C. albicans homolog of
Cln1 targets Cdk1 activity to the Cdc11 septin, which further
suggests the existence of CDK-dependent pathways that regulate
septin function during G1 [45].
Interestingly, shs1D is also synthetically lethal with a member of
the formin family of proteins [46]. There are two formins in budding
yeast that are referred to as Bni1 and Bnr1 [47–51]. Bni1 mediates
nucleationofactinfilamentswithinthebudthatguidevesiclestosites
of polarized growth, while Bnr1 mediates nucleation of actin
filaments at the bud neck that may play a role in guiding vesicles to
the bud neck [52]. Loss of Bni1 causes a widened bud neck and
reduced polar cell growth, while loss of Bnr1 causes only a slight
delay in cell separation [49,53–57]. Loss of both Bni1 and Bnr1 is
lethal and causes severe defects in bud formation, which indicates
that they carry out overlapping functions in events required for bud
formation [47,48,58]. Bnr1-dependent nucleation of actin filaments
is dependent upon the septins [52]. Moreover, bni1D is synthetically
lethal with shs1D and with pho85D [46,59]. Thus, Shs1 may be
required for Bnr1-dependent nucleation of actin filaments, which
would explain the synthetic lethal interaction between shs1D and
bni1D. Taken together, these genetic interactions suggest that Shs1
and the other septins may play a role in redundant formin-
dependent pathways that help direct secretory vesicles to the correct
locations during cell growth. Experiments in vertebrate cells have
also suggested that the septins carry out roles in the secretory
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scaffold for recruitment of proteins that are required for Bnr1-
dependent nucleation of actin filaments, or as a diffusion barrier that
restricts localization of proteins required for formation of a new bud
to the site of bud emergence.
Shs1 is phosphorylated by Pho85-Pcl1 on consensus and
non-consensus sites
Pho85 phosphorylates Shs1 on non-consensus sites in vitro and
the same sites are phosphorylated in vivo. Since Cdk1 acts
redundantly with Pho85 to phosphorylate Shs1, it is likely that
Cdk1 phosphorylates the same non-consensus sites. Previous work
provides another example of phosphorylation of non-consensus
sites by a CDK [60]. In this case, Cdk1-Clb2 was found to
phosphorylate both consensus sites and non-consensus sites on the
Swe1 kinase. Phosphorylation of the non-consensus sites was
detected both in vivo and in vitro, and phosphorylation of non-
consensus sites was dependent upon phosphorylation of consensus
sites in vivo. Phosphorylation of consensus sites on Swe1 therefore
appears to facilitate phosphorylation of non-consensus sites. More
recent experiments have similarly found that Cdk1-Cln2 phos-
phorylates Boi1 on both consensus and non-consensus sites, and
that phosphorylation of consensus sites is required for phosphor-
ylation of non-consensus sites in vivo [6]. These observations could
be explained by a model in which phosphorylation of consensus
sites creates a binding site for Cdk1-cyclin, which generates a high
local concentration of Cdk1-cyclin that drives phosphorylation of
non-consensus sites that would otherwise be kinetically unfavored.
The Clb2 cyclin has been shown to bind to phosphorylated Cdk1
consensus sites, which supports such a model [61].
A number of observations suggest that phosphorylation of Shs1
on consensus sites may work similarly to facilitate further
phosphorylation of non-consensus sites. In the in vitro phosphor-
ylation experiments we recovered a form of Shs1 that was
phosphorylated primarily on consensus sites, and a second form
that was phosphorylated on both consensus sites and non-
consensus sites, which suggests that phosphorylation of consensus
sites is required for phosphorylation of non-consensus sites. We
also found that mutation of consensus sites caused a significant
Figure 7. Phosphorylation of Shs1 regulates association of Shs1 with the Gin4 kinase and causes increased cell size and defects in
cell morphology that are due to delayed entry into mitosis. (A) Extracts made from wild type, gin4D, shs1-ps2, shs1-ps3, and shs1-ps4 cells
were arrested in mitosis with benomyl, and Gin4 was immunoprecipitated using an affinity purified anti-Gin4 polyclonal antibody. Co-precipitationo f
and Shs1 was assayed by Western blotting. The amount of Gin4 in the extracts and bound to the beads was assayed by Western blotting. (B) Cells of
the indicated genotypes were grown in YPD media to log phase at 34uC and photographed. Bar, 5 mm for all panels. (C) clb1D clb3D clb4D, shs1D
clb1D clb3D clb4D, shs1-ps4 clb1D clb3D clb4D, and swe1D shs1-ps4 clb1D clb3D clb4D cells were grown to log phase in YPD media at 30uC and
photographed. Bar, 5 mm for all panels.
doi:10.1371/journal.pone.0002022.g007
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vivo. Since the fully hyperphosphorylated form of Shs1 corre-
sponds to the form that is phosphorylated on non-consensus sites,
this suggests that failure to phosphorylate consensus sites causes a
significant reduction in phosphorylation of non-consensus sites.
Some phosphorylated forms of Shs1 that are dependent upon
CDK activity are present throughout the cell cycle, but Pcl1, Pcl2,
Cln1,and Cln2 are onlypresentduringG1.Phosphorylation of Shs1
at times other than G1 may be due to Cdk1-Cln3, which is thought
to be active throughout the cell cycle [35]. Interpretation of the role
of Cln3 in Shs1 phosphorylation is complicated by the fact that Cln3
functions in a pathway that helps trigger transcription of the other
G1 cyclins [35,36]. Thus, Cdk1-Cln3 could play important roles in
Shs1 phosphorylation by directly phosphorylating Shs1 and by
helping initiate transcription of the other G1 cyclins.
All phosphorylation of Shs1 by Pho85-Pcl1 occurs outside of the
known functional domains of Shs1. It therefore seems unlikely that
phosphorylation of Shs1 by Pho85-Pcl1 directly regulates the
intrinsic GTP or phosphoinositide binding activities of Shs1.
Comparison of the in vitro and in vivo phosphorylation site
mapping experiments revealed that kinases other than Pho85
phosphorylate the GTP-binding domain of Shs1. The Gin4 and
Rad53 kinases have been found to phosphorylate Shs1 and may be
responsible for phosphorylation of these sites [13,62].
Phosphorylation of Shs1 by G1 cyclin-CDKs is required for
regulation of events that occur during G2/M
Since shs1D is synthetically lethal with cln1D cln2D and is
phosphorylated by Pho85-Pcl1, we initially hypothesized that Shs1
is downstream of Pho85-Pcl1 in a pathway that helps control bud
neck formation and the pattern of growth. Surprisingly, however,
we found that shs1-ps mutants were not synthetically lethal with
cln1D cln2D and had no effect on the localization of Cdc11.
Rather, the shs1-ps mutants caused an increased cell size and a
failure to suppress polar growth that appeared to be due to a
Swe1-dependent G2/M delay.
The shs1-ps mutants also caused complex effects on the
association of Shs1 with the Gin4 kinase during mitosis. Previous
work found that loss of Gin4 causes a Swe1-dependent G2/M
delay that leads to formation of elongated cells [42,63]. Moreover,
the phenotype of gin4D is strongly enhanced in Clb2-dependent
cells [42]. The similar phenotypes of gin4D and the shs1-ps
mutants, combined with the finding that phosphorylation of Shs1
appears to regulate association with Gin4, suggests that interac-
tions between Gin4 and Shs1 may be required for normal
progression through G2/M.
One might imagine several models that could explain the role of
phosphorylation of Shs1 by G1 cyclin-CDKs. Phosphorylation of
Shs1 could regulate recruitment of Gin4 or other proteins that
function to redirect growth away from the bud tip, thereby ending
polar growth. Other possible models involve checkpoint functions
for phosphorylation of Shs1. For example, previous work
suggested the existence of a checkpoint that monitors septin
assembly and induces a Swe1-dependent G2/M delay in response
to defects in septin assembly [63,64]. Shs1 phosphorylation could
therefore generate a positive signal that indicates when septin
assembly has occurred normally. However, a complete loss of
septin function caused by temperature sensitive alleles of Cdc3 or
Cdc12 causes a prolonged G2/M delay, whereas gin4D, shs1D, or
shs1-ps cause only a mild G2/M delay [11,17,42]. Therefore,
phosphorylation of Shs1 cannot be the only signal that indicates
that septin assembly is normal.
Phosphorylation of Shs1 by G1 cyclin-CDKs could also be part
of a checkpoint that monitors polar bud growth. Polar growth is
initiated by G1 cyclin-CDKs and must be terminated when
sufficient growth has occurred. Phosphorylation of Shs1 by G1
cyclin-CDKs could help link successful completion of polar growth
events to entry into mitosis. In this case, polar growth would be
expected to continue inappropriately in shs1-ps mutants, which
would lead to growth of cells that are slightly elongated and
abnormally large. These kinds of checkpoint mechanisms must
exist to coordinate cell growth with the cell cycle, yet little is known
about them. The fact that the septins are required for localization
of Bnr1 and for the normal pattern of growth in cln1D cln2D cells
demonstrates that the septins are involved in growth-related events
and may therefore be good candidates for proteins that help
monitor growth. Further analysis of the function and regulation of
Shs1 phosphorylation may therefore provide clues to how cells
coordinate cell growth with the cell cycle.
Materials and Methods
Media and strains
Standard yeast media were used. YPD and YPGal media were
supplemented with 40 mg/liter of adenine. All strains are isogenic
to W303 (leu2-3,112 ura3-52 can1-100 ade2-1 his3-11 trp1-11 ssd1).
The additional features of the strains used in this study are listed in
Table 2. DK516 and DK1032 were generated using standard
genetic crosses and tetrad analysis. To create DK515 and DK548,
the GAL1 promoter and 3XHA was integrated upstream of CLN2
using standard procedures (oligos: ACTCTATAGCTGCCAAT-
TTTTAAAC and TGATGACGAGTCCCAT-ACGGGGTCTT-
GGTTCAGCACTAGCGCACTGAGCAGCGTAATCTG) [65].
To create DK1080, DK1096, and DK1106, three repeats of the
HA epitope were integrated downstream of SHS1 using standard
procedures (oligos: TTATTTATTTGCTCAGCTTTGGATTTT-
GTACAGATACAACGAATTCGAGCTCGTTTAAAC with CA-
CGTATACTGATTTAGCCTCTATTGCATCGGGTAGAGAT-
CGGAT-CCCCGGGTTAATTAA for DK1080, or with CGCG-
TATGCTGATTTAGCCGCTA-TTGCATCGGGTAGAGATC-
GGATCCCCGGGTTAATTAA for DK1096 or with CACGTA-
TACTGATTTAGCCGCTATTGCATCGGGTAGAGATCGGA-
TCCCCGG-GTTAATTAA for DK1106). DK573 was made by
using PCR to amplify pcl1D::natMX6 from BY1404 (gift from Brenda
Andrews)andpcl2D::kanMX6 from the yeast haploid deletion collection
(Open Biosystems) followed by transformation of the PCR products
into DK186 using standard procedures. Similarly, DK1051 was made
by using PCR to amplify swe1D::URA from SH24 followed by
transformation of the PCR product into DK1031. To create DK1068,
a plasmid (pCLN2-HA) that contained Cln2 fused to three repeats of
the HA epitope was linearized with PvuII to target integration at the
CLN2 gene and then transformed into DK573. To create the shs1-ps
mutants a plasmid that included the wild type SHS1 gene was made by
using PCR to amplify the SHS1 open reading frame and flanking
control regions (oligos: GCGGGATCCGCGACTTGA-ACCATT-
CAGTC and GCGGCATGCGAAGTTACGGGAAATCATGA-
TAG).This fragment wasthen cloned into the BamH1 and Sph1sit esof
the YCPlac111 vector to create pTE2. pTE2 was mutagenized by site-
directed mutagenesis to convert T6 to an alanine to create pTE15. To
create shs1-ps1, pTE15 was further mutagenized to convert S447 to an
alanine (pTE17). To create shs1-ps2, pTE15 was cut with restriction
enzymes Msc1a n dBspEII to drop out a 328 bp fragment. This
fragment was replaced with a synthesized fragment that contained
mutations of the four consensus sites at T386, S416, S441, and S447 to
alanines (pTE13). The shs1-ps3 and shs1-ps4 alleles were constructed by
using PCR to amplify a 1308 bp fragment (oligos: CCGCGA-
TAAAATTGCTCAA-TTGGCACCA and ATTAGGACCAAT-
TTCTTCAGCGTTGGCC) of pTE15 and a 787 bp fragment
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GTGTGTTCCCTTCTTGAAGGCTGTG) from plasmids pTE18
and pTE19. pTE18 contained a synthesized fragment that included
mutations of the twelve sites at T386, S416, S441, S447, S460, T462,
S519, S520, S521, S522, S525, and S545 to alanines and was used to
make shs1-ps3. pTE19 contained a synthesized fragment that included
mutations of the nineteen sites at S350, T351, T386, S416, S441,
S447, T454, S460, T462, S519, S520, S521, S522, S525, S529, T530,
T539, T541, and S545 to alanines and was used to make shs1-ps4.
These PCR fragments were gel purified and pieced together by PCR
amplification (oligos: CCGCGATAAAATTGCTCAATTG-GCA-
CCA and TATGTG-TGTTCCCTTCTTGAAGGCTGTG) to
create full length shs1-ps3 and shs1-ps4.T h eshs1-ps mutants were
integrated into the genome at the SHS1 locus as previously described
[60]. The entire open reading frame of all shs1-ps mutants was verified
by sequencing. All gene synthesis was carried out by DNA 2.0, Menlo
Park, California.
Immunofluorescence, cell cycle arrests, and centrifugal
elutriation
Fixation and staining of cells with antibodies was carried out as
previously described [66]. Cells were arrested in G1 by addition of
0.5 mg/ml a factor to log phase cultures, followed by growth at
room temperature for 3 hours. Small, unbudded cells were
isolated from log phase cells by centrifugal elutriation in a
Beckman J6-MI centrifuge and a JE-5.0 rotor as previously
described [67].
Sample preparation, PAGE, and Western blotting
Samples for time courses were collected as previously described
with the exception that glass beads were added before freezing and
115 ml of 1X sample buffer supplemented with 2 mM PMSF,
50 mM NaF, 50 mM b-glycero-phosphate, and 5% b-mercapto-
ethanol was added to frozen pellets before bead beating [42]. The
phosphorylated forms of Shs1 were resolved on a 10%
polyacrylamide gel (14 cm wide69 cm long61 mm thick) for
3.5 hours at constant current (20 mA) [68]. Western blot transfers
were carried out for 2 hours at 400 mA at 4uC in a Hoeffer
transfer tank in a buffer containing 200 mM tris base, 1.5 M
glycine, and 20% methanol.
Immunoaffinity purifications of Shs1-3XHA
Immunoaffinity purification of Shs1-3XHA for in vitro
phosphorylation by Pho85-Pcl1 was carried out in the presence
Table 2. Strains used in this study
Strain Genotype Reference or Source
CC7 MATa, bar1D, cdc12-6 This study
CC10 MATa, bar1D, SHS1-3XHA-URA3 [17]
DK186 MATa, bar1D [42]
DK212 MATa, bar1D, clb1D, clb3D::TRP1, clb4D::HIS3 [42]
DK223 MATa, bar1D, clb1D, clb3D::TRP1, clb4D::HIS3 clb2D::LEU2 ura3::GAL10-CLB2 This study
DK252 MATa, bar1D, cln1D::his5+, cln2D::LEU2, ura3::GAL1-CLN3 Gift from Bruce Futcher
DK515 MATa, bar1D,s h s 1 D::URA3, cln1D::TRP1, GAL1-CLN2-3XHA his5+ This study
DK516 MATa, bar1D, cdc12-6, cln1D::TRP1, cln2D::LEU2 This study
DK548 MATa, bar1D, cln1D::TRP1, GAL1-CLN2-3XHA his5+ This study
DK573 MATa, bar1D,p c l 1 D::natMX6, pcl2D::kanMX6 This study
DK747 MATa, bar1D, shs1D::URA3 This study
DK912 MATa, bar1D, shs1::shs1-ps2 This study
DK966 MATa, bar1D, shs1::shs1-ps1 This study
DK985 MATa, bar1D, shs1::shs1-ps4 This study
DK1031 MATa, bar1D, shs1::shs1-ps4 This study
DK1032 MATa, bar1D, shs1::shs1-ps4, clb1D, clb3D::TRP1, clb4D::HIS3 This study
DK1033 MATa, bar1D, shs1::shs1-ps3 This study
DK1051 MATa, bar1D, shs1::shs1-ps4, clb1D, clb3D::TRP1, clb4D::HIS3, swe1D::URA3 This study
DK1068 MATa, bar1D,p c l 1 D::natMX6, pcl2D::kanMX6, CLN2-3XHA-LEU2 This study
DK1080 MATa, bar1D, shs1::shs1-ps2-3XHA his5+ This study
DK1096 MATa, bar1D, shs1::shs1-ps4-3XHA kanMX6 This study
DK1106 MATa, bar1D, shs1::shs1-ps3-3XHA his5+ This study
KA61 MATa, bar1D, cln1D::TRP1, cln2D::LEU2 This study
RA19 MATa, bar1D, gin4D::LEU2 This study
RA25 MATa, bar1D,s h s 1 D::URA3, clb1D, clb3D::TRP1, clb4D::HIS3 [17]
SH24 MATa, bar1D,s w e 1 D::URA3 [71]
SH183 MATa, bar1D, pho85D::kanMX6 This study
SH184 MATa, bar1D, cln3D::HIS5 This study
ZZ41 MATa, bar1D, CLN2-3XHA-LEU2 [72]
doi:10.1371/journal.pone.0002022.t002
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Gin4, with the following changes [13]. To purify Shs1-3XHA
without lambda phosphatase treatment, cells were lysed in a buffer
that contained 50 mM HEPES-KOH, pH 7.6, 1 M KCl, 75 mM
b-glycero-phosphate, 75 mM NaF, 1 mM MgCl2, 1 mM EGTA,
0.45% Tween-20, 10% glycerol, 1 mM phenylmethylsulfonyl
fluoride (PMSF) and the column was washed in the same buffer
without PMSF. The elution buffer was the same as the lysis buffer
except that it contained 0.5 mg/ml HA dipeptide, 0.01% Tween-
20, and no PMSF. To purify Shs1-3XHA treated with lambda
phosphatase, cells were lysed in buffer containing 50 mM HEPES-
KOH, pH 7.6, 1 M KCl, 1 mM MgCl2, 1 mM EGTA, 0.45%
Tween-20, 5% glycerol, 1 mM PMSF. After the extracts were
incubated with the immunoaffinity beads, the beads were washed
twice batchwise with 15 ml of lysis buffer and then twice with
15 ml of phosphatase buffer (50 mM Tris-HCl, pH 7.5, 5 mM
DTT, 2 mM MnCl2, 100 mg/ml BSA). The beads were
transferred to a 1.6 ml tube and then washed 5 times with 1 ml
of phosphatase buffer. The beads were pelleted, the supernatant
was removed, and the beads were incubated with 20 mL of lambda
phosphatase (New England Biolabs) for 45 min at 30uC, with
gentle mixing every 5 min. The beads were transferred to a 1.5-ml
Biospin column (Bio-Rad) and washed with 5 ml of wash buffer
(50 mM HEPES-KOH, pH 7.6, 200 mM KCl, 1 mM MgCl2,
1 mM EGTA, 5% glycerol, 0.01% Tween-20) by pipeting 1-ml
aliquots of buffer on top of the column and allowing the buffer to
flow through by gravity. The column was eluted as described for
the Shs1-3XHA that was not treated with phosphatase.
Purification of 6XHIS-Pho85/GST-Pcl1 complexes and
3XHA-Cln2/Cdk1
Full length PCL1 was amplified by PCR and cloned into a
Gateway entry vector (pDONR221) to create pTE4 (oligos for first
round of PCR: AACCTGTACTTCCAGTCCATGTGTGAA-
TACAGCAAGGC and GTACAAGAAA-GCTGGGTCCTA-
AAACCCATGTTGACTCATG and oligos for second round of
PCR: GGGGACAAGTTTGTACAAAAAAGCAGGCTCCGA-
AAACCTGTACTTCC-AG and GGGGACCACTTTGTA-
CAAGAAAGCTGGGTCGGACTGGAAGTACAG-GTT). The
DNA was verified by sequencing and then recombined into a
Gateway destination vector (pDEST15) to fuse glutathione-S-
transferase (GST) to the N-terminus of Pcl1 (pTE6). Full length
PHO85 from a cDNA library was amplified by PCR and cloned
into Gateway entry vector PCR8/TOPOA to create pTE7 (oligos:
CGCATGTCTTCTTCTTCACAATTTAAGC and CGCTT-
ATGAAGCGT-GGTGGTAGTAC). The DNA was verified by
sequencing and then recombined into a Gateway destination
vector (pDEST17 with AMP replaced with KAN, gift from John
Little) to fuse six histidines at the N-terminus of Pho85 (pTE9).
pTE6 and pTE9 were co-transformed into BL21 Arabinose cells
and plated on LB plates containing 50 mg/ml kanamicin and
100 mg/ml ampicillin. Cells carrying these plasmids were grown to
an optical density of 1.0 at 37uC, chilled on ice until they reached
25uC, and then induced with 0.2% L-Arabinose for 4 hours at
room temperature. Cells were pelleted, frozen in liquid nitrogen,
and stored at 280uC. Purification of the 6XHIS-Pho85/GST-
Pcl1 complex was carried out by successive glutathione and nickel
affinity chromatography as previously described for Gin4, with the
following changes [17]. The glutathione affinity chromatography
was performed as previously described, with the exception that the
column was eluted with a buffer containing 50 mM phosphate,
pH 8.0, 100 mM NaCl, 5 mM reduced glutathione [69]. The
eluted 6XHIS-Pho85/GST-Pcl1 complex was loaded directly
onto a 1 ml Ni-NTA column, washed with 20 column volumes
50 mM phosphate pH 8.0, 500 mM NaCl, 5 mM b-mercapto-
ethanol, 10 mM imidizole, and eluted with 50 mM phosphate
pH 7.0, 500 mM NaCl, 250 mM imidizole pH 7.0. The yield
from 4 liters of culture was ,1.5 mg. Peak fractions were pooled
and dialyzed in 75 mM HEPES-KOH, pH 7.6, 10% glycerol,
1 mM DTT, 0.05% Tween-20, 1 mM MgCl2 and frozen in liquid
nitrogen. 3XHA-Cln2/Cdk1 was purified by immunoaffinity
chromatography and used in kinase assays as previously described
[70].
Kinase assays
To demonstrate that Shs1 is directly phosphorylated by Pho85-
Pcl1, increasing amounts of purified 6XHIS-Pho85/GST-Pcl1
were added to the purified dephosphorylated Shs1-3XHA in the
presence of kinase assay buffer (50 mM HEPES-KOH, pH 7.6,
2 mM MgCl2, 0.05% Tween-20, 10% glycerol, 1 mM DTT,
1 mM ATP). The reactions were incubated at 30uC for 1 hour and
terminated by the addition of 2.5 ml of 4X sample buffer. The
samples were incubated at 100uC for 5 minutes and loaded onto a
10% SDS polyacrylamide gel, which was transferred to nitrocel-
lulose and probed with a-HA antibody. Reactions with purified
3XHA-Cln2/Cdk1 were carried out in a similar manner.
Phosphorylation-site mapping by Tandem Mass
Spectrometry
To map in vitro phosphorylation sites on Shs1, we scaled up the
reactions in Figure 5C, lane 4. Both hyperphosphorylated Shs1
protein bands and an unphosphorylated control band were excised
from the gel. Phosphorylation sites were mapped on all three forms
of Shs1. No phosphorylation sites were identified on the unpho-
sphorylated control sample. To map in vivo sites on Shs1, Shs1-
3XHA was affinity purified in the presence of phosphatase
inhibitors to prevent dephosphorylation of Shs1, as previously
described for purification of in vivo phosphorylated Swe1 [60].
Coomassie blue-stained bands corresponding to Shs1 protein
were reduced, carboxiamidomethylated, and digested indepen-
dently with trypsin and chymotrypsin for increased sequence
coverage. Peptide mixtures were separated by microcapillary
(125 mM618 cm) reverse-phase (MagicC18AQ) chromatography
and online analyzed on a hybrid mass spectrometer (LTQ-
Orbitrap or LTQ-FT, Thermo Electron), in a data-dependent
fashion. Precursor masses were collected at high resolution; MS/
MS spectra were triggered for the ten most abundant ions and
acquired in the linear ion trap. MS/MS spectra were searched
using the Sequest algorithm with serine, threonine, and tyrosine
phosphorylation and methionine oxidation as dynamic modifica-
tions. Peptide matches obtained were deemed correct after
applying several filtering criteria, including mass error
,10 ppm, tryptic ends for trypsin digested samples. Redundant
identifications of phosphorylation sites derived from different
digestions added confidence to our results. Further, all spectra
corresponding to phosphopeptides were manually inspected for
correct sequence identification validation and site assignment
based on the presence of site determining fragment ions.
Ambiguity is denoted when applicable (see Table 1 legend).
Coimmunoprecipitation of Gin4 and Shs1
Immunoaffinity beads for the precipitation of Gin4 were made
as previously described [13]. To prepare cells for immunoprecip-
itation experiments, 50 ml of cells at OD600 0.7 were resuspended
in YPD containing 30 mg/ml benomyl, followed by growth at
room temperature for 3 hours. Cells were pelleted, resuspended in
3 ml of 50 mM HEPES-KOH, pH 7.6, and aliquoted into two
The Septins Function in G1
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nitrogen after removing the supernatant. Extracts and immuno-
precipitation were carried out as previously described [13].
Supporting Information
Figure S1 Shs1 phosphorylation site mutants localize normally.
shs1-ps2-3XHA, shs1-ps3-3XHA, and shs1-ps4-3XHA cells were
grown to log phase. Shs1 localization was determined with an anti-
HA antibody.
Found at: doi:10.1371/journal.pone.0002022.s001 (4.56 MB TIF)
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